Ask AI
ProCE Banner Activity

Complementing PARP Inhibition in Metastatic CRPC: Optimal Use of PARP Inhibitor Combination Therapy

Slideset

Download this slideset featuring expert perspective on the most recent clinical trials and guideline recommendations on using PARP inhibitor combination therapy for patients with mCRPC.

Released: May 30, 2025

Expiration: November 29, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Johnson & Johnson and Pfizer Inc.

Johnson & Johnson

Pfizer, Inc.